Lexaria Bioscience (LEXX) EBITDA Yield: History & Chart

Lexaria Bioscience Corp.(LEXX)

Biotechnology · Kelowna, BC

$2.92+0.15 (+5.24%)

Delayed quote: Oct 6, 2026, 12:09 PM EDT

About Lexaria Bioscience Corp.

Lexaria Bioscience Corp. is a biotechnology company focused on advanced drug delivery. Its proprietary and patented DehydraTECH technology is designed to significantly improve the oral delivery of active pharmaceutical ingredients, enhancing their absorption into the bloodstream. This innovative platform has shown impressive results, boosting the bioavailability of compounds such as cannabinoids and nicotine by 5 to 10 times, and in some cannabinoid applications, by as much as 27 times, when compared to standard formulations. DehydraTECH also drastically cuts the time of onset from hours to mere minutes and effectively neutralizes unpleasant tastes. Beyond its established uses, the technology is currently under evaluation for its potential application with orally administered antiviral drugs, non-steroidal anti-inflammatory drugs (NSAIDs), PDE5 inhibitors, and various other compounds. A notable feature of DehydraTECH is its capacity to facilitate the passage of drugs across the blood-brain barrier. The company operates a licensed internal research facility and holds a substantial intellectual property portfolio, comprising 23 granted patents and roughly 50 pending patent applications globally. Founded in 2004, Lexaria Bioscience Corp. is headquartered in Kelowna, Canada.

Kelowna, BC

7 employees

www.lexariabioscience.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Richard C. Christopher

View full financials

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
Lexaria Bioscience Corp. (LEXX)	$4.82M	N/A	N/A	N/A	N/A
CalciMedica, Inc. (CALC)vs ›	$4.66M	N/A	N/A	N/A	N/A
Bio Green Med Solution, Inc. (BGMS)vs ›	$4.64M	N/A	N/A	N/A	N/A
Imunon, Inc. (IMNN)vs ›	$5.04M	N/A	N/A	N/A	N/A
PharmaCyte Biotech, Inc. (PMCB)vs ›	$4.58M	N/A	N/A	N/A	N/A
CollPlant Biotechnologies Ltd. (CLGN)vs ›	$4.53M	N/A	2.09%	2.09%	2.09%
Dermata Therapeutics, Inc. (DRMA)vs ›	$4.49M	N/A	N/A	N/A	N/A
Basel Medical Group Ltd Ordinary Shares (BMGL)vs ›	$5.17M	N/A	N/A	N/A	N/A
Lunai Bioworks Inc. (LNAI)vs ›	$5.17M	N/A	N/A	N/A	N/A
Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs ›	$5.17M	N/A	N/A	N/A	N/A

NAME

MARKET CAP

EBITDA YIELD

TTM

Lexaria Bioscience Corp. (LEXX)

$4.82M

N/A

CalciMedica, Inc. (CALC)vs ›

$4.66M

N/A

Bio Green Med Solution, Inc. (BGMS)vs ›

$4.64M

N/A

Imunon, Inc. (IMNN)vs ›

$5.04M

N/A

PharmaCyte Biotech, Inc. (PMCB)vs ›

$4.58M

N/A

CollPlant Biotechnologies Ltd. (CLGN)vs ›

$4.53M

N/A

2.09%

Dermata Therapeutics, Inc. (DRMA)vs ›

$4.49M

N/A

Basel Medical Group Ltd Ordinary Shares (BMGL)vs ›

$5.17M

N/A

Lunai Bioworks Inc. (LNAI)vs ›

$5.17M

N/A

Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs ›

$5.17M

N/A

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

EBITDA Yield: N/A

LEXX EBITDA Yield Metrics

LEXX Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

Related Metrics